Enantiomeric drug development: Issues, considerations, and regulatory requirements
โ Scribed by Nuggehally R. Srinivas; Rashmi H. Barbhaiya; Kamal K. Midha
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 201 KB
- Volume
- 90
- Category
- Article
- ISSN
- 0022-3549
- DOI
- 10.1002/jps.1074
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
This paper reviews several emerging and recurrent issues relating to the drug development process. These emerging issues include changes to the FDA regulatory environment, internationalization of drug development, advances in computer technology and visualization tools, and e!orts to incorporate met
Data from the rapid systematic study of the fate of a new drug in rats and dogs can aid the design of pharmacological and safety tests and can provide a basis for biopharmaceutic and Phase I clinical trials. Keyphrases Drug metabolism-role in drug research and development, symposium Biopharmaceutics